SCHEMBL23972148

SCHEMBL23972148

c1ccc(-c2ccc3c(n2)oc2cc4ccccc4cc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
RAB9A P51151 2/20 0.38
TDO2 P48775 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
ALDH1A1 P00352 2/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPK1 P28482 1/20 0.36
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
NPC1 O15118 1/20 0.36
HTT P42858 1/20 0.36
ALK Q9UM73 1/20 0.35
ADORA2A P29274 3/20 0.35
AURKA O14965 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31439258 0.81 MEN1 (0.42) KMT2AMEN1RAB9ATDO2SMN1; SMN2
SCHEMBL443891 0.81 MEN1 (0.42) KMT2AMEN1RAB9ATDO2SMN1; SMN2
SCHEMBL23348907 0.77 TBK1 (0.46) KMT2AMEN1RAB9ATDO2SMN1; SMN2
SCHEMBL23349946 0.77 ALDH1A1 (0.44) KMT2AMEN1RAB9ATDO2ALDH1A1
SCHEMBL26424219 0.77 PRKDC (0.35) KMT2AMEN1RAB9AALDH1A1HSD17B10
SCHEMBL24911485 0.76 TBK1 (0.33) KMT2AMEN1RAB9ASMN1; SMN2TP53
SCHEMBL26424199 0.75 HCRTR1 (0.33) KMT2AMEN1ALDH1A1KDM4EESR1
SCHEMBL18853366 0.75 SMN1; SMN2 (0.46) KMT2AMEN1RAB9ATDO2SMN1; SMN2
SCHEMBL24762954 0.74 MEN1 (0.42) KMT2AMEN1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL24762377 0.73 MEN1 (0.44) KMT2AMEN1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210343950-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210343950-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES AOX1, OCIAD1, OCIAD2 KMT2A 1952/4885MEN1 4654/4885RAB9A 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.